C. Michalik

Epidemiological composition, clinical and treatment characteristics of the patient cohort of the german competence network for HIV/AIDS

T. Harrer, M. Rausch, K. Jansen, 2009, European journal of medical research.

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.

T. Harrer, A. Jetter, A. Owen, 2011, The Journal of antimicrobial chemotherapy.

Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)-Containing Regimens in Treatment-Experienced Patients with HIV

S. Esser, N. Brockmeyer, P. Puglièse, 2013, Current HIV research.

Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.

A. Mocroft, H. Günthard, D. Podzamczer, 2013, The Journal of infectious diseases.

The male ScreenING Study: prevalence of HPV‐related genital and anal lesions in an urban cohort of HIV‐positive men in Germany

A. Kreuter, N. Brockmeyer, U. Wieland, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis

S. Esser, A. Guignard, N. Brockmeyer, 2013, BMC Infectious Diseases.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.

K. Metzner, A. d’Arminio Monforte, A. Schultze, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis

K. Überla, R. Gold, A. Chan, 2015, Multiple sclerosis.

The patient cohort of the German competence network for HIV/AIDS (KompNet):a profile

S. Esser, H. Jaeger, K. Jansen, 2009, European journal of medical research.

Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS

G. Arendt, E. Wolf, M. Rausch, 2011, Infection.

Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition

B. Schmidt, H. Walter, R. Kaiser, 2011, Journal of acquired immune deficiency syndromes.

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis

K. Überla, R. Gold, A. Chan, 2015, Multiple sclerosis.